Destroy Metastatic Cancers

1
Destroy Metastatic Cancers
2

• Integrative Cancer Centers of America ("ICCA")
  offers Conexus, a "tumor-busting" cancer therapy
  designed to destroy (debulk, shrink, reduce, or
  neutralize) late stage primary or metastasized
  solid tumors, even those classified "inoperable"
  by respected Comprehensive Cancer Centers
  regardless of where domiciled.

3

• The Conexus treatment protocol consists of
  several FDA approved oxidants and non-toxic
  antigen enhancers injected directly into the
  tumor using very small gauge needle while under
  CT guidance. Each treatment is typically once a
  week for three consecutive weeks, takes less than
  45 minutes to perform, minimally invasiveness,
  with minimal or no side-effects.

4
(No Transcript)
5
Conexus is designed to serve three vitally
important functions

• Debulk late stage and/or inoperable solid tumors
  without surgery, radiation, or chemotherapy, and
  without causing collateral damage to any
  surrounding tissue, even when the tumor is
  classified inoperable by many well-intended
  Comprehensive Cancer Centers.

6

• Suppress cancer metastasis through manufacturing
  of select autologous tumor antigens formulated to
  enhance cancer cell apoptosis (death) which is a
  primordial event for activating T-cell response
  and the inherent benefits found therein.

7

• Dendritic Cancer Vaccine to induce immune
  cellular response within select cancer cells that
  serve to destroy, slow, or even reverse
  progressive tumor growth.

8
(No Transcript)
9
Our Physicians

• ICCA physicians are highly trained and qualified
  to employ safe and effective cancer treatments
  which have undergone rigorous clinical trials and
  studies in many global medical venues such as
  Germany, United States, Canada, Cuba, United
  Kingdom, South Korea, China and of course Mexico
  (National Cancer Institute), among others.

10

• ICCA physicians are well-trained in compounding
  cancer fighting medicines unique to a particular
  cancer type, at its affiliate compounding
  pharmacy located near the clinic, and when
  necessary, employ a vast array of cancer fighting
  tools/devices that more often than not, are
  unavailable to well-intended physicians
  practicing outside of Mexico.

11

• ICCA physicians choose to practice medicine in
  Mexico, which is one of a handful of
  industrialized nations that allow licensed
  physicians to practice medicine wherein a very
  special relationship is created between physician
  and patient,

12
(No Transcript)
13

• encouraging the treating physician to offer
  whatever treatment protocols he or she deems
  necessary to facilitate more favorable patient
  outcomes and recoveries.

14

• For more update, visit us

https//integrativecancercentersofamerica.com/
15
(No Transcript)